Bellino, R <br/><br/>
Epidoxorubicin and paclitaxel as primary chemotherapy for T > 3 cm and T4 breast cancer patients.  [electronic resource] 

 -  Anticancer research   
 - 4825-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>0250-7005 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Combined Chemotherapy Protocols--administration & dosage<br/>Breast Neoplasms--drug therapy<br/>Chemotherapy, Adjuvant<br/>Cyclophosphamide--administration & dosage<br/>Disease Progression<br/>Disease-Free Survival<br/>Epirubicin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Lymph Node Excision<br/>Lymphatic Metastasis<br/>Mastectomy, Modified Radical<br/>Mastectomy, Segmental<br/>Methotrexate--administration & dosage<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Neoplasm Staging<br/>Paclitaxel--administration & dosage